• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Clifford Goodman on What to Look Forward to at the Fall 2017 ACO Coalition Meeting

Video

Ongoing legislative developments and the latest experiences with implementing alternative payment mechanisms are just some of the reasons Clifford Goodman, PhD, senior vice president and director at the Center for Comparative Effectiveness Research at the Lewin Group, is looking forward to the fall meeting of the ACO & Emerging Healthcare Delivery Coalition.

Ongoing legislative developments and the latest experiences with implementing alternative payment mechanisms are just some of the reasons Clifford Goodman, PhD, senior vice president and director at the Center for Comparative Effectiveness Research at the Lewin Group, is looking forward to the fall meeting of the ACO & Emerging Healthcare Delivery Coalition.

Transcript (slightly modified)

Why should someone attend the fall meeting of the ACO & Emerging Healthcare Delivery Coalition, being held October 26-27 in Nashville, Tennessee?

Thinking about the fall meeting in Nashville, I’m already looking forward to that because of a few things. One is that by then, we’re going to see a lot more of how the healthcare legislation is going to be playing out. What really will have happened to the Affordable Care Act? Will there really be a new AHCA [American Health Care Act] in place? Those contextual trends are going to be very important for understanding where we go next with the ACO Coalition. That’s a very important thing.

Also, I see a trend, or I should say kind of an ongoing continuous development, of shared learning among our people that do attend this meeting on an ongoing basis. We continue to develop, learn from, refine, and then continue to implement these different sort of models, value-based models, for really providing alternative payment mechanisms for accountable care organizations and others to better serve our patient populations.

It’s the changes in the political environment, certainly advances in sciences and the state-of-the-art, and the ongoing exchange of on-the-ground experience that will make an event like that really successful.

Related Videos
Screenshot of Susan Wescott, RPh, MBA
Screenshot of an interview with Adam Colborn, JD
Screenshot of an interview with James Chambers, PhD
Screenshot of an interview with Megan Ehret, PharmD
Interview screenshot with Megan Ehret, PharmD
Screenshot of an interview with Susan Wescott, RPh, MBA
Screenshot of an interview with Nadine Barrett, PhD
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.